Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil

Journal of Surgical Oncology

Volumn 100, Issue 6, 2009, Pages 452-455

  Fanelli, Marcello F ^a   De Paiva Jr , Tadeu F ^a   Silva, Milton J B ^a   Benevides, Carlos F L ^a   Guimarães, Andréa P G ^a   Gimenes, Daniel L ^a   Pinheiro, Edilson D ^a   Rinck Jr , José A ^a   Nicolau, Ulisses R ^a   Sanches, Solange M ^a   Mello, Celso A L ^a   Dettino, Aldo L A ^a   Cruz, Marcelo R S ^a   De Melo, Leila Maria M P ^a   Formiga, Maria N C ^a   De Lima, Vladmir C C ^a   Chinen, Ludmilla T D ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Multivariate analysis; Neoplasm metastasis; Peritoneum; Prognosis; Stomach neoplasms

Indexed keywords

ADULT; ARTICLE; BLOOD VESSEL INJURY; BRAZIL; CANCER STAGING; CARCINOMATOSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PERITONEUM CANCER; PERITONEUM METASTASIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; SIGNET RING CARCINOMA; STOMACH CANCER; VISCERAL METASTASIS;

ADULT; CARCINOMA, SIGNET RING CELL; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 70350346913     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21349     Document Type: Article

References (32)

1. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-2150. (Pubitemid 46655601)
2. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543.
3. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
4. Brasil, Ministério da Saúde. INCA,- Instituto Nacional de Câncer. Estimativa de incidência e mortalidade por câncer no Brasil. 2008. Available at: http://www.inca.gov.br/estimativa/2008/.
5. Sugarbaker PH, Yonemura Y: Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: Best palliation with a ray of hope for cure. Oncology 2000;58:96-107.
6. Al-Shammaa HA, Li Y, Yonemura Y: Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol 2008;14:1159-1166. (Pubitemid 351356322)
7. Chau I, Norman AR, Cunningham D, et al.: Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 2004;22:2395-2403. (Pubitemid 41121931)
8. Kim JG, Ryoo BY, Park YH, et al.: Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy. Cancer Chemother Pharmacol 2008;61:301-307. (Pubitemid 350160328)
9. Lee J, Lim T, Uhm JE, et al.: Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma. Ann Oncol 2007;18:886-891. (Pubitemid 47054086)
10. Fanelli MF, Silva MJB, de Paiva TF, Jr., et al.: Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil. Int J Clin Oncol in press.
11. American Joint Committee on Cancer. AJCC cancer staging manual. 6th edition. Philadelphia: Lippincott Williams & Wilkins.
12. Sadeghi B, Arvieux C, Glehen O, et al.: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358-363. (Pubitemid 30051820)
13. Roviello F, Marrelli D, de Manzoni G, et al.: Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 2003;90:1113-1119. (Pubitemid 37152170)
14. Ohno S, Maehara Y, Ohiwa H, et al.: Peritoneal dissemination after a curative gastrectomy in patients with undifferentiated adenocarcinoma of the stomach. Semin Surg Oncol 1994;10:117-120. (Pubitemid 24181266)
15. Yoo CH, Noh SH, Shin DW, et al.: Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-242. (Pubitemid 30088655)
16. Maehara Y, Moriguchi S, Kakeji Y, et al.: Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 1991;110:820-823.
17. Moriguchi S, Kamakura T, Odaka T, et al.: Clinical features of the differentiated and undifferentiated types of advanced gastric carcinoma: Univariate and multivariate analyses. J Surg Oncol 1991;48:202-206.
18. Moriguchi S, Maehara Y, Korenaga D, et al.: Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol 1992;1:341-346.
19. Marrelli D, Roviello F, de Manzoni G, et al.: Different patterns of recurrence in gastric cancer depending on Lauren's histological type: Longitudinal study. World J Surg 2002;26:1160-1165. (Pubitemid 36920276)
20. Li C, Kim S, Lai JF, et al.: Advanced gastric carcinoma with signet ring cell histology. Oncology 2007;72:64-68. (Pubitemid 350249131)
21. Pande R, Sunga A, Levea C, et al.: Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum 2008;51:50-55.
22. Harrison JD, Fielding JW: Prognostic factors for gastric cancer influencing clinical practice. World J Surg 1995;19:496-500.
23. Ikeguchi M, Katano K, Oka A, et al.: Relationship between hematogenic metastasis of gastric cancer and the maximum extent of venous invasion by cancer cells in the gastric wall. Hepatogastroenterology 1995;42:660-665.
24. Maehara Y, Oshiro T, Baba H, et al.: Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery 1995;117:380-385.
25. Noguchi Y: Blood vessel invasion in gastric carcinoma. Surgery 1990;107:140-148.
26. Lehnert T, Erlandson RA, Decosse JJ: Lymph and, blood capillaries of the human gastric mucosa. A morphologic basis for metastasis in early gastric carcinoma. Gastroenterology 1985;89:939-950.
27. Maehara Y, Hasuda S, Koga T, et al.: Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 2000;87:353-357. (Pubitemid 30156364)
28. Glehen O, Mithieux F, Osinsky D, et al.: Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol 2003;21:799-806. (Pubitemid 46606438)
29. Roviello F, Marrelli D, Neri A, et al.: Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): Postoperative outcome and risk factors for morbidity. World J Surg 2006;30:2033-2040; discussion 2041-12032
30. Stewart JH, Shen P, Levine EA: Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: Current status and future directions. Ann Surg Oncol 2005;12:765-777. (Pubitemid 41355928)
31. Yonemura Y, Kawamura T, Bandou E, et al.: Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005;92:370-375. (Pubitemid 40445602)
32. Yan TD, Black D, Sugarbaker PH, et al.: A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007;14:2702-2713. (Pubitemid 47460649)